Depression and anxiety were each associated with a higher risk of major adverse cardiac events, with the greatest risk observed when both conditions co-occurred, and these associations were partly mediated by heightened stress-related neural activity and downstream autonomic and inflammatory dysregulation. In more than 85,000 participants from the Mass General Brigham Biobank (2010–2020) followed for a median of 3.4 years, depression increased the risk of major adverse cardiac events (hazard ratio, 1.24), an effect that was stronger for individuals with concurrent anxiety and depression (hazard ratio, 1.35) and remained significant after extensive adjustment for confounders. In subgroups with imaging and biomarker data, depression and anxiety were linked to higher amygdala-to-prefrontal cortex activity, reduced heart rate variability, and elevated C-reactive protein levels, all markers of stress-related autonomic and immune activation. Mediation analyses confirmed that these neural and physiological pathways partially explained the relationship between depression, anxiety and cardiac risk, highlighting shared stress-related mechanisms. Source: https://www.ahajournals.org/
A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2…
A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that…
A comprehensive prospective study tracking over 159,000 adults for up to three decades has provided…
A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months…
A large-scale study involving 103,649 UK Biobank participants has revealed that adhering to healthy dietary…
To address uncertainties in statin safety profiles, which are often based on observational data susceptible…
This website uses cookies.